in isolated heart muscle preparations from patients with endstage heart failure ( due to dilated cardiomyopathy ) beta-adrenergic as well as alpha 1-adrenergic effects are reduced compared to preparations from healthy hearts .
C0018801
heart failure
C0018787
hearts